Forian Inc (FORA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Forian Inc (FORA) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.22 Million) by net assets ($29.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FORA stock market capitalisation for the company's overall valuation and market capitalisation.
Forian Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Forian Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Forian Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Forian Inc ranked by their cash flow conversion efficiency. Explore FORA operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sewoon Medical Co. Ltd
KQ:100700
|
0.019x |
|
Tailyn Technologies
TWO:5353
|
0.003x |
|
Xtant Medical Holdings Inc
NYSE MKT:XTNT
|
0.106x |
|
Atlantic International Corp. Common Stock
NASDAQ:ATLN
|
-0.154x |
|
Tsann Kuen Enterprise Co Ltd
TW:2430
|
0.135x |
|
Safety Shot Inc
NASDAQ:SHOT
|
-0.072x |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
-0.106x |
|
Great Elm Group Inc
NASDAQ:GEG
|
0.146x |
Annual Cash Flow Conversion Efficiency for Forian Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Forian Inc from 2019 to 2025. View Forian Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $29.78 Million | $2.89 Million | 0.097x | +929.98% |
| 2024-12-31 | $30.05 Million | $282.83K | 0.009x | -64.20% |
| 2023-12-31 | $27.72 Million | $728.82K | 0.026x | +103.81% |
| 2022-12-31 | $12.42 Million | $-8.58 Million | -0.691x | -0.80% |
| 2021-12-31 | $25.17 Million | $-17.25 Million | -0.685x | -81.64% |
| 2020-12-31 | $11.27 Million | $-4.25 Million | -0.377x | -110.27% |
| 2019-12-31 | $-281.03K | $-1.03 Million | 3.674x | -- |
About Forian Inc
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical … Read more